CY1119468T1 - Φαρμακευτικες συνθεσεις οι οποιες περιεχουν αλισποριβιρη - Google Patents
Φαρμακευτικες συνθεσεις οι οποιες περιεχουν αλισποριβιρηInfo
- Publication number
- CY1119468T1 CY1119468T1 CY20171101068T CY171101068T CY1119468T1 CY 1119468 T1 CY1119468 T1 CY 1119468T1 CY 20171101068 T CY20171101068 T CY 20171101068T CY 171101068 T CY171101068 T CY 171101068T CY 1119468 T1 CY1119468 T1 CY 1119468T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing risk
- risk
- alisporivir
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- OLROWHGDTNFZBH-XEMWPYQTSA-N Alisporivir Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(CC)C(=O)[C@@H](C)N(C)C1=O OLROWHGDTNFZBH-XEMWPYQTSA-N 0.000 abstract 1
- 229950004789 alisporivir Drugs 0.000 abstract 1
- 108010058359 alisporivir Proteins 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η εφεύρεση παρέχει φαρμακευτικές συνθέσεις που βασίζονται σε λιπίδια οι οποίες περιέχουν αλισποριβίρη.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42249910P | 2010-12-13 | 2010-12-13 | |
| IB2011000319 | 2011-02-18 | ||
| IB2011000653 | 2011-03-25 | ||
| PCT/EP2011/072463 WO2012080176A2 (en) | 2010-12-13 | 2011-12-12 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119468T1 true CY1119468T1 (el) | 2018-03-07 |
Family
ID=45346477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171101068T CY1119468T1 (el) | 2010-12-13 | 2017-10-12 | Φαρμακευτικες συνθεσεις οι οποιες περιεχουν αλισποριβιρη |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20140005123A1 (el) |
| EP (1) | EP2651396B1 (el) |
| JP (2) | JP6259288B2 (el) |
| KR (1) | KR101928589B1 (el) |
| CN (2) | CN103282022A (el) |
| AR (1) | AR084235A1 (el) |
| AU (3) | AU2011344331A1 (el) |
| BR (1) | BR112013014606A2 (el) |
| CA (1) | CA2819167C (el) |
| CL (1) | CL2013001684A1 (el) |
| CO (1) | CO6761388A2 (el) |
| CY (1) | CY1119468T1 (el) |
| DK (1) | DK2651396T3 (el) |
| EC (1) | ECSP13012679A (el) |
| ES (1) | ES2643135T3 (el) |
| HR (1) | HRP20171485T1 (el) |
| HU (1) | HUE036784T2 (el) |
| IL (1) | IL226554A (el) |
| JO (1) | JO3337B1 (el) |
| LT (1) | LT2651396T (el) |
| MA (1) | MA34709B1 (el) |
| MX (1) | MX351667B (el) |
| MY (1) | MY165088A (el) |
| NZ (1) | NZ610950A (el) |
| PE (1) | PE20140104A1 (el) |
| PL (1) | PL2651396T3 (el) |
| PT (1) | PT2651396T (el) |
| RU (1) | RU2639482C2 (el) |
| SG (2) | SG10201509833YA (el) |
| SI (1) | SI2651396T1 (el) |
| TW (1) | TWI599368B (el) |
| WO (1) | WO2012080176A2 (el) |
| ZA (1) | ZA201303721B (el) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103347882B (zh) | 2010-12-13 | 2016-05-11 | 阵列生物制药公司 | 作为III型受体酪氨酸激酶抑制剂的取代的N-(1H-吲唑-4-基)咪唑并[1,2-a]吡啶-3-甲酰胺化合物 |
| JO3337B1 (ar) | 2010-12-13 | 2019-03-13 | Debiopharm Sa | تركيبات صيدلية تشمل أليسبوريفير |
| WO2015008223A1 (en) | 2013-07-17 | 2015-01-22 | Novartis Ag | Treatment of hepatitis c virus infection with alisporivir and ribavirin |
| WO2015136455A1 (en) | 2014-03-13 | 2015-09-17 | Novartis Ag | New treatments of hepatitis c virus infection |
| AR114930A1 (es) * | 2017-09-12 | 2020-11-11 | Novartis Ag | Composición farmacéutica |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1274354A (fr) | 1956-03-10 | 1961-10-27 | Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol | |
| KR0148748B1 (ko) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
| GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| FR2697040B1 (fr) | 1992-10-21 | 1994-12-30 | Ind Entreprise | Elément de protection contre le bruit et son utilisation. |
| GB9405304D0 (en) | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
| SE504582C2 (sv) * | 1995-07-06 | 1997-03-10 | Gs Dev Ab | Cyklosporinkomposition baserad på en L2-fas |
| ID25908A (id) | 1998-03-06 | 2000-11-09 | Novartis Ag | Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida |
| JP2002513750A (ja) * | 1998-05-07 | 2002-05-14 | エラン コーポレーシヨン ピーエルシー | 溶媒／助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム |
| USRE40987E1 (en) * | 1998-07-01 | 2009-11-17 | Debiopharm S.A. | Cyclosporin with improved activity profile |
| GB9903547D0 (en) * | 1999-02-16 | 1999-04-07 | Novartis Ag | Organic compounds |
| GB0001928D0 (en) * | 2000-01-27 | 2000-03-22 | Novartis Ag | Organic compounds |
| US6979672B2 (en) * | 2002-12-20 | 2005-12-27 | Polichem, S.A. | Cyclosporin-based pharmaceutical compositions |
| GB0320638D0 (en) | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
| ATE490778T1 (de) * | 2004-10-01 | 2010-12-15 | Debiopharm Sa | Verwendung von äd-mealaü3-äetvalü4-ciclosporin zur behandlung von hepatitis-c-infektion |
| EP1830871A1 (en) | 2004-12-23 | 2007-09-12 | Novartis AG | Compositions for hcv treatment |
| GB0504950D0 (en) | 2005-03-10 | 2005-04-20 | Novartis Ag | Organic compositions |
| CA2741829A1 (en) | 2008-11-06 | 2010-05-14 | Debio Recherche Pharmaceutique S.A. | Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| JO3337B1 (ar) | 2010-12-13 | 2019-03-13 | Debiopharm Sa | تركيبات صيدلية تشمل أليسبوريفير |
-
2011
- 2011-12-11 JO JOP/2011/0373A patent/JO3337B1/ar active
- 2011-12-12 BR BR112013014606A patent/BR112013014606A2/pt not_active Application Discontinuation
- 2011-12-12 EP EP11794739.0A patent/EP2651396B1/en active Active
- 2011-12-12 JP JP2013543687A patent/JP6259288B2/ja not_active Expired - Fee Related
- 2011-12-12 SG SG10201509833YA patent/SG10201509833YA/en unknown
- 2011-12-12 KR KR1020137018234A patent/KR101928589B1/ko active IP Right Grant
- 2011-12-12 PE PE2013001400A patent/PE20140104A1/es active IP Right Grant
- 2011-12-12 SI SI201131314T patent/SI2651396T1/sl unknown
- 2011-12-12 PL PL11794739T patent/PL2651396T3/pl unknown
- 2011-12-12 CN CN2011800598202A patent/CN103282022A/zh active Pending
- 2011-12-12 US US13/992,948 patent/US20140005123A1/en not_active Abandoned
- 2011-12-12 SG SG2013040712A patent/SG190894A1/en unknown
- 2011-12-12 AR ARP110104622A patent/AR084235A1/es unknown
- 2011-12-12 CA CA2819167A patent/CA2819167C/en not_active Expired - Fee Related
- 2011-12-12 CN CN201510548088.5A patent/CN105125489B/zh not_active Expired - Fee Related
- 2011-12-12 HU HUE11794739A patent/HUE036784T2/hu unknown
- 2011-12-12 AU AU2011344331A patent/AU2011344331A1/en not_active Abandoned
- 2011-12-12 RU RU2013132543A patent/RU2639482C2/ru not_active IP Right Cessation
- 2011-12-12 WO PCT/EP2011/072463 patent/WO2012080176A2/en active Application Filing
- 2011-12-12 TW TW100145812A patent/TWI599368B/zh not_active IP Right Cessation
- 2011-12-12 LT LTEP11794739.0T patent/LT2651396T/lt unknown
- 2011-12-12 DK DK11794739.0T patent/DK2651396T3/en active
- 2011-12-12 MX MX2013006525A patent/MX351667B/es active IP Right Grant
- 2011-12-12 PT PT117947390T patent/PT2651396T/pt unknown
- 2011-12-12 NZ NZ610950A patent/NZ610950A/en not_active IP Right Cessation
- 2011-12-12 MY MYPI2013001865A patent/MY165088A/en unknown
- 2011-12-12 ES ES11794739.0T patent/ES2643135T3/es active Active
-
2013
- 2013-05-22 ZA ZA2013/03721A patent/ZA201303721B/en unknown
- 2013-05-23 IL IL226554A patent/IL226554A/en active IP Right Grant
- 2013-06-05 MA MA35960A patent/MA34709B1/fr unknown
- 2013-06-12 CL CL2013001684A patent/CL2013001684A1/es unknown
- 2013-06-13 EC ECSP13012679 patent/ECSP13012679A/es unknown
- 2013-06-14 CO CO13142692A patent/CO6761388A2/es unknown
-
2016
- 2016-02-19 AU AU2016201053A patent/AU2016201053B2/en not_active Ceased
- 2016-05-12 US US15/153,035 patent/US10188696B2/en not_active Expired - Fee Related
-
2017
- 2017-08-24 JP JP2017161652A patent/JP2018027949A/ja active Pending
- 2017-10-04 HR HRP20171485TT patent/HRP20171485T1/hr unknown
- 2017-10-09 AU AU2017245296A patent/AU2017245296A1/en not_active Abandoned
- 2017-10-12 CY CY20171101068T patent/CY1119468T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119468T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιεχουν αλισποριβιρη | |
| UY34134A (es) | Contenedor aislado | |
| CL2012002979A1 (es) | Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona. | |
| EA201390145A1 (ru) | Конъюгаты, частицы, композиции и связанные с ними способы | |
| UY34456A (es) | Anticuerpos anti-il-36r | |
| CR20140229A (es) | Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona | |
| UY34587A (es) | Formulaciones estabilizadas que contienen anticuerpos antiang2 | |
| UY33958A (es) | Inhibidores de la glucosilceramida sintasa | |
| UY34536A (es) | Nucleósidos sustituidos, nucleótidos y análogos de los mismos | |
| UY34177A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa tipo 10a | |
| UY34817A (es) | Tienopirimidinas | |
| IN2012DN06714A (el) | ||
| UY34365A (es) | Compuestos heterociclicos | |
| CR20130539A (es) | Triazolopiridinas | |
| UY34027A (es) | Inhibidores sustituidos de acetil-coa carboxilasa. | |
| TR201909271T4 (tr) | Testosteron formülasyonları. | |
| UY34527A (es) | ?composiciones, métodos y kits para la preparación de proteínas recombinantes sialiladas?. | |
| UY34442A (es) | 2-tiopirimidinonas. | |
| UY4153Q (es) | Batería | |
| UA107476C2 (uk) | Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів | |
| CL2009001973S1 (es) | Mostrador. | |
| UY34407A (es) | Nuevos moduladores de trpv3 | |
| UY4152Q (es) | Batería | |
| UY34501A (es) | ?procedimiento de purificación de factor viii?. | |
| CL2011000028S1 (es) | Envase dispensador |